I'll give you the benefit of the doubt and assume

I'll give you the benefit of the doubt and assume that you are relatively new to Nanologix.

The announcement didn't do much since it went out to only those who have signed up for the updates; people who are likely already invested to their satisfaction and not likely to invest further in any significant amount.

Those in the medical community who have read the N-Assay publication is likely very interested in the technology, but not necessarily the Company. You are fooling yourself and others with a false premise thinking otherwise.

We may get a bump up after the conference. But be careful as manipulators have taken investors on a roller coaster ride before and may use such tactics again to discourage potential investors. In the long run, I see the stock price much higher than it is now. I am holding for when a big pharma buys the Company, which I think will happen sooner than later after the conference and other developments which I am sure is in the works.